NRGene Overview

  • Founded
  • 2009
  • Status
  • Public
  • Employees
  • 55
  • Stock Symbol
  • NRGN
Stock Symbol
  • Share Price
  • $8.95
  • (As of Sunday Closing)

NRGene General Information


Energin R Technologies 2009 Ltd is a genomics company that provides turn-key solutions. It is engaged in developing AI based genomics software for seed and food companies. By applying vast proprietary databases and AI-based technologies, it provides international agriculture, seed and food companies, with computational tools to optimize and accelerate the breeding programs, significantly increasing crop yield and saving time and money.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Stock Exchange
Primary Office
  • 5 Golda Meir Street
  • Ness Ziona 7403649
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NRGene Stock Performance

(As of Sunday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.95 $8.56 $8.41 - $9.23 7.6K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NRGene Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NRGene‘s full profile, request access.

Request a free trial

NRGene Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Energin R Technologies 2009 Ltd is a genomics company that provides turn-key solutions. It is engaged in developing AI b
Ness Ziona, Israel
55 As of 2020
0000 0000-00-00
00000000 0000


piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
Bangalore, India
000000000 00.000


t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labor
Branford, CT
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NRGene Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InterpretOmics Corporate Backed or Acquired Bangalore, India 00.000 000000000 00.000
0000000 Corporation Branford, CT
000000 00000000 Venture Capital-Backed Saint Sulpice, Switzerland 000 00000 00000000000 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

NRGene Executive Team (5)

Name Title Board Seat Contact Info
Gil Ronen Ph.D Co-Founder & Chief Executive Officer
Ehud Belder Chief Financial Officer
Guy Kol Co-Founder & Senior Vice President, Product & Strategic Alliances
Omer Barad Ph.D Vice President, Research & Development
You’re viewing 4 of 5 executive team members. Get the full list »

NRGene Board Members (1)

Name Representing Role Since
David Lieber NRGene Chairman 000 0000
To view NRGene’s complete board members history, request access »

NRGene Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial